Time to Colonoscopy After Positive Fecal Blood Test in Four U.S. Health Care Systems
Overview
Oncology
Public Health
Authors
Affiliations
Background: To reduce colorectal cancer mortality, positive fecal blood tests must be followed by colonoscopy.
Methods: We identified 62,384 individuals ages 50 to 89 years with a positive fecal blood test between January 1, 2011 and December 31, 2012 in four health care systems within the Population-Based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium. We estimated the probability of follow-up colonoscopy and 95% confidence intervals (CI) using the Kaplan-Meier method. Overall differences in cumulative incidence of follow-up across health care systems were assessed with the log-rank test. HRs and 95% CIs were estimated from multivariate Cox proportional hazards models.
Results: Most patients who received a colonoscopy did so within 6 months of their positive fecal blood test, although follow-up rates varied across health care systems (P <0.001). Median days to colonoscopy ranged from 41 (95% CI, 40-41) to 174 (95% CI, 123-343); percent followed-up by 12 months ranged from 58.1% (95% CI, 51.6%-63.7%) to 83.8% (95% CI, 83.4%-84.3%) and differences across health care systems were also observed at 1, 2, 3, and 6 months. Increasing age and comorbidity score were associated with lower follow-up rates.
Conclusion: Individual characteristics and health care system were associated with colonoscopy after positive fecal blood tests. Patterns were consistent across health care systems, but proportions of patients receiving follow-up varied. These findings suggest that there is room to improve follow-up of positive colorectal cancer screening tests.
Impact: Understanding the timing of colonoscopy after positive fecal blood tests and characteristics associated with lack of follow-up may inform future efforts to improve follow-up.
Subramanian S, Tangka F, Hoover S, Mathews A, Redwood D, Smayda L Cancer Causes Control. 2024; 35(11):1467-1476.
PMID: 39107449 PMC: 11670815. DOI: 10.1007/s10552-024-01898-w.
Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death.
Doubeni C, Corley D, Jensen C, Levin T, Ghai N, Cannavale K JAMA Netw Open. 2024; 7(7):e2423671.
PMID: 39028667 PMC: 11259903. DOI: 10.1001/jamanetworkopen.2024.23671.
Patterns of Care Following a Positive Fecal Blood Test for Colorectal Cancer: A Mixed Methods Study.
Hahn E, Munoz-Plaza C, Jensen C, Ghai N, Pak K, Amundsen B J Gen Intern Med. 2024; 39(16):3205-3216.
PMID: 38771535 PMC: 11618562. DOI: 10.1007/s11606-024-08764-0.
Shareef F, Bharti B, Garcia-Bigley F, Hernandez M, Nodora J, Liu J J Prim Care Community Health. 2024; 15():21501319241242571.
PMID: 38554066 PMC: 10981848. DOI: 10.1177/21501319241242571.
Development of a Follow-Up Measure to Ensure Complete Screening for Colorectal Cancer.
Ciemins E, Mohl J, Moreno C, Colangelo F, Smith R, Barton M JAMA Netw Open. 2024; 7(3):e242693.
PMID: 38526494 PMC: 10964113. DOI: 10.1001/jamanetworkopen.2024.2693.